Grace

RSV Vaccine Study

Main objective:

This study will be enrolling pregnant women to receive an investigational vaccine intended to reduce the frequency of RSV infections in newborns.

Who are we looking for?

  • 24-34 weeks of pregnancy
  • No major health problems in mother/fetus
  • Interested in possible reduction of chance of RSV pneumonia in baby
  • Willing to have infant followed for first year of life

What’s provided for duration of study:

  • Investigational vaccine administered to mother
  • Close follow-up of infant for 1 year
  • Modest payments for visits pre/post birth
  • Opportunity to help reduce incidence of RSV pneumonia
CONTACT US

If you would like additional information, please send us an email or give us a call!

334-504-7020
volunteerinfo@secclinicalresearch.com

Thank you for your interest – we look forward to hearing from you!

Interested in Volunteering for Our Research Studies?

Give Us A Call
334-504-7016
Send Us An Email

volunteerinfo@secclinicalresearch.com

SEC Clinical Research

Dothan

217 Graceland Drive Ste 3
Dothan, AL 36305

SEC Clinical Research
Pensacola

2441 N. 9th Avenue Ste B
Pensacola, FL 32503

Facebook Instagram

© 2023 SEC CLINICAL RESEARCH - ALL RIGHTS RESERVED